| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Scinai Immunotherapeutics Ltd.
13G/A
09073Q203
|
6.3% |
7/9/2026
Event 4/27/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.